Nature's Way Holding Company names Randy J. Rose President/CEO and Rory
Mahony Chief Operating Officer of new natural medicine powerhouse
GREEN BAY, Wis., Nov. 10 /PRNewswire/ -- Representatives of the Dr. Willmar Schwabe Group, of Karlsruhe, Germany, have confirmed that corporate ownership for Enzymatic Therapy, Inc., of Green Bay, Wisconsin, was transferred on Friday, October 31, 2008.
A shareholder group comprised of North Castle Partners, LLC, and members of Enzymatic Therapy Management previously owned Enzymatic Therapy, Inc.
Details of the sale price are unavailable, as is information regarding the combined revenue of the entities.
The North American operating platform for the Schwabe group will be named Nature's Way Holding Company, and will include the entire operations of Enzymatic Therapy, Inc. and Nature's Way Products Inc.
The combined group will create an organization with great depth of technical and scientific expertise that will market a very broad line of wellness products and natural medicines.
Nature's Way Holding Company will continue to bring trusted consumer solutions forward under highly popular brand names that include Nature's Way(tm), Alive(tm), Zucol(tm), Umcka(tm), Pearls(tm) Whole Body Cleanse(tm), Remifemin(R), and Enzymatic Therapy(R).
Additionally, the company will continue to market professional products sold only through medical professionals under labels that include Integrative Therapeutics(R).
Nature's Way Holding Company has confirmed to its customers that all merchandising and marketing programs previously announced for both product lines will continue. The Company also will continue to distribute products to over 40 countries outside the United States.
Randy J. Rose, formerly the President and CEO of Enzymatic Therapy, has
been named the President and CEO of the combined business, and Rory Mahony,
who previously served as COO & General Manager of Nature
|SOURCE Nature's Way Holding Company|
Copyright©2008 PR Newswire.
All rights reserved